Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
QuintilesIMS
Citi
Accenture
Fish and Richardson
Healthtrust
Teva
McKesson
UBS
Novartis

Generated: February 19, 2018

DrugPatentWatch Database Preview

Mallinckrodt Ip Company Profile

« Back to Dashboard

What is the competitive landscape for MALLINCKRODT IP, and what generic alternatives to MALLINCKRODT IP drugs are available?

MALLINCKRODT IP has one approved drug.

There are four US patents protecting MALLINCKRODT IP drugs.

There are forty-eight patent family members on MALLINCKRODT IP drugs in twenty-six countries.

Summary for Mallinckrodt Ip
International Patents:48
US Patents:4
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Mallinckrodt Ip

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt Ip OFIRMEV acetaminophen SOLUTION;IV (INFUSION) 022450-001 Nov 2, 2010 AP RX Yes Yes 6,992,218*PED ➤ Sign Up Y ➤ Sign Up
Mallinckrodt Ip OFIRMEV acetaminophen SOLUTION;IV (INFUSION) 022450-001 Nov 2, 2010 AP RX Yes Yes 9,610,265 ➤ Sign Up ➤ Sign Up
Mallinckrodt Ip OFIRMEV acetaminophen SOLUTION;IV (INFUSION) 022450-001 Nov 2, 2010 AP RX Yes Yes 9,399,012*PED ➤ Sign Up Y ➤ Sign Up
Mallinckrodt Ip OFIRMEV acetaminophen SOLUTION;IV (INFUSION) 022450-001 Nov 2, 2010 AP RX Yes Yes ➤ Sign Up ➤ Sign Up
Mallinckrodt Ip OFIRMEV acetaminophen SOLUTION;IV (INFUSION) 022450-001 Nov 2, 2010 AP RX Yes Yes ➤ Sign Up ➤ Sign Up
Mallinckrodt Ip OFIRMEV acetaminophen SOLUTION;IV (INFUSION) 022450-001 Nov 2, 2010 AP RX Yes Yes 6,028,222*PED ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for MALLINCKRODT IP drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 1000 mg/100 mL (10 mg/mL) ➤ Subscribe 4/7/2011

International Patents for Mallinckrodt Ip Drugs

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Daiichi Sankyo
McKesson
Queensland Health
Julphar
Colorcon
Mallinckrodt
QuintilesIMS
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot